Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco

Diabetes, Metabolic Syndrome and Obesity

Volumn 7, Issue , 2014, Pages 341-346

  El Brini, Otmane ^a   Akhouayri, Omar ^a   Gamal, Allal ^b   Mesfioui, Abdelhalem ^a   Benazzouz, Bouchra ^a  

^a IBN TOFAIL UNIVERSITY   (Morocco)

^b Diagnostic Center   (Morocco)

Author keywords

Central obesity; Cholesterol; Glucose intolerance; Hypertension; Triglyceride

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOROCCO; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84905445543     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S61245     Document Type: Article

References (34)

1. Benjelloun S. Nutrition transition in Morocco. Public Health Nutr. 2002;5:135-140.
2. El ayachi M, Mziwira M, Vincent S, et al. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. Eur J Clin Nutr. 2005;59:1379-1386.
3. Essiarab F, Taki H, El Malki A, Hassar M, Saile R, Ghalim N. Cardiovascular risk factors prevalence in a Moroccan population. Eur J Sci Res. 2011;49(4):581-589.
4. Jesmin S, Islam MR, Islam AM, et al. Comprehensive assessment of metabolic syndrome among Rural Bangladeshi Women. BMC Public Health. 2012;12:49.
5. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all cause and cardiovascular disease mortality in men. Arch Intern Med. 2004;164:1092-1097.
6. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
7. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
8. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
9. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulindependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36:553-559.
10. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
11. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation. 2003;108:1552-1553.
12. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-636.
13. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010;2:180-193.
14. Vernay M, Salanave B, de Peretti C, et al. Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006-2007). Int J Public Health. 2013;58:855-864.
15. Corbatón-Anchuelo A, Martínez-Larrad MT, Fernández-Pérez C, et al. Metabolic syndrome, adiponectin, and cardiovascular risk in Spain (the Segovia study): impact of consensus societies criteria. Metab Syndr Relat Disord. 2013;11(5):309-318.
16. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
17. Belfki H, Ben Ali S, Aounallah-Skhiri H, et al. Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project. Public Health Nutr. 2013;16:582-590.
18. Alzahrani AM, Karawagh AM, Alshahrani FM, Naser TA, Ahmed AA, Alsharef EH. Prevalence and predictors of metabolic syndrome among healthy Saudi Adults. Br J Diabetes Vasc Dis. 2012;12:78-80.
19. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications. 2007;21:214-219.
20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
21. Tazi MA, Abir-Khalil S, Chaouki N, et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. J Hypertens. 2003;21:897-903.
22. Aparicio VA, Ortega FB, Carbonell Baeza A, et al. Fitness, fatness and cardiovascular profile in South Spanish and North Moroccan women. Nutr Hosp. 2011;26:1188-1192.
23. King H, Rewers M. Global estimates of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157-177.
24. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Sendai: Department of public health, Tohoku University school of Medicine; 1960.
25. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among usus Adolescents, 1999-2000. Diabetes Care. 2004;27:2438-2443.
26. Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3:204-211.
27. Motala AA, Esterhuizen T, Pirie FJ, Omar MA. Prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care. 2011;34: 1032-1037.
28. Anagnostis P. Metabolic syndrome in the Mediterranean region: Current status. Indian J Endocrinol Metab. 2012;16:72-80.
29. Maharjan BR, Bhandary S, Shrestha I, Sunuwar L, Shrestha S. Prevalence of Metabolic Syndrome in Local Population of Patan. Medical Journal of Shree Birendra Hospital. 2012;11:27-31.
30. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia. 2001;44:537-543.
31. Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010;50:99-105.
32. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Type 2 diabetes and the metabolic syndrome in Japanese Americans. Diabetes Res Clin Pract. 2000;50:S73-S76.
33. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-2094.
34. Sattar N, Gaw A, Scherbakova O. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-419.